CymaBay Therapeutics to Present at the 42nd Annual JP Morgan Healthcare Conference 2024

January 2, 2024

https://www.globenewswire.com/news-release/2024/01/02/2802612/37067/en/CymaBay-Therapeutics-to-Present-at-the-42nd-Annual-JP-Morgan-Healthcare-Conference-2024.html

NEWARK, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a biopharmaceutical company focused on innovative therapies for patients with liver and other chronic diseases, today announced that its President and Chief Executive Officer, Sujal Shah, will present at the upcoming 42nd Annual JP Morgan Healthcare Conference taking place January 8 -11 in San Francisco, California.

Read more at globenewswire.com

Related news for (CBAY)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.